Editorials

Corticosteroids in the management of croup

BMJ 1995; 311 doi: http://dx.doi.org/10.1136/bmj.311.7015.1244 (Published 11 November 1995) Cite this as: BMJ 1995;311:1244
  1. Iolo Doull
  1. Senior registrar in paediatric intensive care Great Ormond Street Hospital for Children NHS Trust, Institute of Child Health, London WC1N 3JH

    Nebulised corticosteroids are the treatment of choice

    Although croup is one of the commonest childhood complaints, its treatment has been empirical at best. Traditional management at home consists of creating a warm moist atmosphere by placing the child in a steam filled bathroom with the hot water taps running, but there is no objective evidence that this treatment is effective. Nebulised adrenaline is commonly prescribed in North America, and although it is of proved benefit, its effect is short lived.1 Corticosteroids have been advocated, but until recently their use was contentious because of conflicting reports.2 3 4

    Croup, or laryngotracheobronchitis, is most commonly seen in children aged 6 months to 4 years. It is caused by viral infection, usually with parainfluenza virus, although infection with influenza, respiratory syncitial virus, or rhinovirus may cause a similar clinical picture. Croup is characterised by a harsh, barking, seal-like cough, stridor, and hoarse voice, with …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe